Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A

Total article views   HTML views PDF downloads Totals
1,774 Dovepress* 1,597+ 45 1,642
PubMed Central* 177 64 241
Totals 1,774 109 1,883
*Since 21 September 2023

View citations on PubMed Central and Google Scholar